Virginia could become the first state in the nation to restrict a new class of generic medications. But drug companies want limits and some pharmacists are concerned.
Amgen is the world’s largest biotech company – a California firm that makes medicines from living cells. These remedies, known as biologicals, are expensive and protected by patents, but the Affordable Care Act clears the way for cheaper, generic forms of these products.